Recombinant interferon-beta muteins
US6514729B1 · kind B1 · utility
69Cited by
17References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 11, 2000 |
| Grant date | Feb 4, 2003 |
| Priority date | — |
| Expiry date | May 11, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel interferon-beta activity (IbA) proteins and nucleic acids. The invention further relates to the use of the IbA proteins in the treatment of IFN-&bgr; related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.